Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia

被引:2163
作者
Weng, AP
Ferrando, AA
Lee, W
Morris, JP
Silverman, LB
Sanchez-Irizarry, C
Blacklow, SC
Look, AT
Aster, JC [1 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA
[2] Harvard Univ, Dana Farber Canc Inst, Sch Med, Dept Pediat Oncol, Boston, MA 02115 USA
关键词
D O I
10.1126/science.1102160
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Very rare cases of human T cell acute lymphoblastic leukemia (T-ALL) harbor chromosomal translocations that involve NOTCH1, a gene encoding a transmembrane receptor that regulates normal T cell development. Here, we report that more than 50% of human T-ALLs, including tumors from all major molecular oncogenic subtypes, have activating mutations that involve the extracellular heterodimerization domain and/or the C-terminal PEST domain of NOTCH1. These findings greatly expand the role of activated NOTCH1 in the molecular pathogenesis of human T-ALL and provide a strong rationale for targeted therapies that interfere with NOTCH signaling.
引用
收藏
页码:269 / 271
页数:3
相关论文
共 25 条
  • [21] p300 and PCA act cooperatively to mediate transcriptional activation from chromatin templates by Notch intracellular domains in vitro
    Wallberg, AE
    Pedersen, K
    Lendahl, U
    Roeder, RG
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (22) : 7812 - 7819
  • [22] Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling
    Weng, AP
    Nam, Y
    Wolfe, MS
    Pear, WNS
    Griffin, JD
    Blacklow, SC
    Aster, JC
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (02) : 655 - 664
  • [23] Therapeutic strategies for Alzheimer's disease
    Wolfe, MS
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (11) : 859 - 866
  • [24] Inactivation of Notch2 impairs VDJβ rearrangement and allows pre-TCR-independent survival of early αβ lineage thymocytes
    Wolfer, A
    Wilson, A
    Nemir, M
    MacDonald, HR
    Radtke, F
    [J]. IMMUNITY, 2002, 16 (06) : 869 - 879
  • [25] Chronic treatment with the γ-secretase inhibitor LY-411,575 inhibits β-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation
    Wong, GT
    Manfra, D
    Poulet, FM
    Zhang, Q
    Josien, H
    Bara, T
    Engstrom, L
    Pinzon-Ortiz, M
    Fine, JS
    Lee, HJJ
    Zhang, LL
    Higgins, GA
    Parker, EM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) : 12876 - 12882